Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue: Role of β-adrenoreceptor subtypes

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 240-246

  Qvisth, Veronica ^a,b   Hagström Toft, Eva ^a   Enoksson, Staffan ^a   Bolinder, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CPG 12177; LACTIC ACID; NORADRENALIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ARTICLE; FEMALE; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; IN VIVO STUDY; MALE; MICRODIALYSIS; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE BLOOD FLOW;

EID: 38149034308     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1313     Document Type: Article

References (45)

1. Brooks GA 2002 Lactate shuttles in nature. Biochem Soc Trans 30:258-264
2. Kreisberg RA 1980 Lactate homeostasis and lactic acidosis. Ann Intern Med 92:227-237
3. Ohlson LO, Larsson B, Björntorp P, Eriksson H, Svärdsudd K, Welin L, Tibblin G, Wilhelmsen L 1988 Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31:798-805
4. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD 1988 Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024
5. Zawadzki JK, Wolfe RR, Mott DM, Lillioja S, Howard BV, Bogardus C 1988 Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction. Diabetes 37:154-159
6. Consoli A, Nurjhan N, Reilly Jr JJ, Bier DM, Gerich JE 1990 Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 86:2038-2045
7. Lovejoy J, Newby FD, Gebhart SS, DiGirolamo M 1992 Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism 41:22-27
8. Qvisth V, Hagström-Toft E, Moberg E, Sjoberg S, Bolinder J 2007 Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am J Physiol Endocrinol Metab 292:E709-E714
9. Jansson PA, Smith U, Lönnroth P 1990 Evidence for lactate production by human adipose tissue in vivo. Diabetologia 33:253-256
10. Hagström E, Arner P, Ungerstedt U, Bolinder J 1990 Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am J Physiol 258(5 Pt 1):E888-E893
11. Hagström-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P 1997 Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol 273(3 Pt 1):E584-E592
12. Ellmerer M, Schaupp L, Sendlhofer G, Wutte A, Brunner GA, Trajanoski Z, Skrabal F, Wach P, Pieber TR 1998 Lactate metabolism of subcutaneous adipose tissue studied by open flow microperfusion. J Clin Endocrinol Metab 83:4394-4401
13. Henry S, Schneiter P, Jequier E, Tappy L 1996 Effects of hyperinsulinemia and hyperglycemia on lactate release and local blood flow in subcutaneous adipose tissue of healthy humans. J Clin Endocrinol Metab 81:2891-2895
14. Deibert DC, DeFronzo RA 1980 Epinephrine-induced insulin resistance in man. J Clin Invest 65:717-721
15. Marangou AG, Alford FP, Ward G, Liskaser F, Aitken PM, Weber KM, Boston RC, Best JD 1988 Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. Metabolism 37:885-891
16. Febbraio MA, Lambert DL, Starkie RL, Proietto J, Hargreaves M 1998 Effect of epinephrine on muscle glycogenolysis during exercise in trained men. J Appl Physiol 84:465-470
17. Watt MJ, Howlett KF, Febbraio MA, Spriet LL, Hargreaves M 2001 Adrenaline pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J Physiol 534(Pt 1):269-278
18. Tossman U, Ungerstedt U 1986 Microdialysis in the study of extracellular levels of amino acids in the rat brain. Acta Physiol Scand 128:9-14
19. Kurpad A, Khan K, Calder AG, Coppack S, Frayn K, Macdonald I, Elia M 1994 Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. Clin Sci (Lond) 86:177-184
20. Larsen OA, Lassen NA, Quaade F 1966 Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 66:337-345
21. Sejrsen P, Tonnesen KH 1968 Inert gas diffusion method for measurement of blood flow using saturation techniques. Comparison with directly measured blood flow in isolated gastrocnemius muscle of the cat. Circ Res 22:679-693
22. Lassen NA, Lindbjerg J, Munck O 1964 Measurement of blood-flow through skeletal muscle by intramuscular injection of Xenon-133. Lancet 15:686-689
23. Hickner RC, Bone D, Ungerstedt U, Jorfeldt L, Henriksson J 1994 Muscle blood flow during intermittent exercise: comparison of the microdialysis ethanol technique and 133Xe clearance. Clin Sci (Lond) 86:15-25
24. Bernst EG 1974 Determination of ethanol with alcohol dehydrogenase and NAD.In: Bergmeyer HU, Gawehn K, eds. Methods of enzymatic analysis. New York: Academic Press; 1499-1515
25. Passoneau J 1974 Lactate: fluorometric method. In: Bergmeyer HU, Gawehn K, eds. Methods of enzymatic analysis. New York: Academic Press; 1468-1472
26. Hallman H, Farnebo LO, Hamberger B, Johnsson G 1978 A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci 23:1049-1052
27. Kurpad A, Khan K, Macdonald I, Elia M 1995 Haemodynamic responses in muscle and adipose tissue and whole body metabolic responses during norepinephrine infusions in man. J Auton Nerv Syst 54:163-170
28. Quisth V, Enoksson S, Blaak E, Hagström-Toft E, Arner P, Bolinder J 2005 Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo. Diabetologia 48:946-953
29. Van Hall G 2000 Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand 168:643-656
30. Hagström-Toft E, Qvisth V, Nennesmo I, Ryden M, Bolinder H, Enoksson S, Bolinder J, Arner P 2002 Marked heterogeneity of human skeletal muscle lipolysis at rest. Diabetes 51:3376-3383
31. Cryer PE 2002 Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45:937-948
32. Mersmann HJ 1998 Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci 76:160-172
33. Jensen J, Brors O, Dahl HA 1995 Different β-adrenergic receptor density in different rat skeletal muscle fibre types. Pharmacol Toxicol 76:380-385
34. Baker JG 2005 Evidence for a secondary state of the human β3-adrenoceptor. Mol Pharmacol 68:1645-1655
35. Hoffstedt J, Lonnqvist F, Shimizu M, Blaak E, Arner P 1996 Effects of several putative β3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes Relat Metab Disord 20:428-434
36. de Souza CJ, Burkey BF 2001 β3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 7:1433-1449
37. Weyer C, Gautier JF, Danforth Jr E 1999 Development of β3-adrenoceptor agonists for the treatment of obesity and diabetes-an update. Diabetes Metab 25:11-21
38. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg AD, Ricquier D, Emorine LJ 1993 Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349
39. Liggett SB, Shah SD, Cryer PE 1988 Characterization of β-adrenergic receptors of human skeletal muscle obtained by needle biopsy. Am J Physiol 254(6 Pt 1):E795-E798
40. Hjemdahl P, Linde B 1983 Influence of circulating NE and Epi on adipose tissue vascular resistance and lipolysis in humans. Am J Physiol 245:H447-H452
41. Chang PC, Kriek E, van der Krogt JA, Blauw GJ, van Brummelen P 1988 Haemodynamic effects of physiological concentrations of circulating noradrenaline in man. Clin Sci (Lond) 75:469-475
42. Navegantes LC, Sjöstrand M, Gudörnsdottir S, Strindberg L, Elam M, Lönnroth P 2003 Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab 88:5515-5520
43. Clark MG, Colquhoun EQ, Rattigan S, Dora KA, Eldershaw TP, Hall JL, Ye J 1995 Vascular and endocrine control of muscle metabolism. Am J Physiol 268(5 Pt 1):E797-E812
44. Ruffolo Jr RR, Nichols AJ, Stadel JM, Hieble JP 1991 Structure and function of alpha-adrenoceptors. Pharmacol Rev 43:475-505
45. Piascik MT, Soltis EE, Piascik MM, Macmillan LB 1996 α-Adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol Ther 72:215-241